Tag Archives: Sales

New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes

Astellas and Seattle Genetics impressed Wall Street last fall when their combination of Padcev and Merck’s Keytruda fought off advanced bladder cancer in previously untreated patients. Friday, the partners presented updated results that look even better. They might even be good enough to snag an expedited regulatory review, analysts say—and at least one market-watcher hiked… Read More »

iWater Group Limited – Successful sales launch in Turkey

London, 06. December 2019 – iWater Group Limited has identified Turkey as an important market for their sales campaign. The geographical location and the climate conditions in Turkey provide ideal conditions for traditional and organic agriculture. Around three million agricultural operations and traditional micro enterprises utilise an area of around 38 million hectares for the… Read More »

Purdue could become a trust funded by sales of the same drug blamed for the opioid crisis

Purdue Pharma could become a public trust funded by OxyContin sales as part of a massive settlement over its role in the opioid epidemic, but some prosecutors and health advocates are skeptical of the idea of relying on profits from the drug that contributed to the crisis. Purdue, commonly blamed as a major contributor to… Read More »

AstraZeneca rockets toward Tagrisso sales target with another survival win

AstraZeneca already has a Tagrisso approval for patients with previously untreated, EGFR-mutated lung cancer. But it’s shoring up its case with some clutch new data. Friday, the British drugmaker said Tagrisso had beaten out Roche’s rival drug Tarceva and AstraZeneca’s own Iressa at helping patients live longer. The showing came as part of the phase 3 Flaura… Read More »